The company
Aytu BioPharma, Inc.
AYTU · Nasdaq
AYTU stood above a rising 150-day average in 25 of the last 52 weekly readings, and has been out of that trend for the last 23 weeks. It is 11.1% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 23
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 35 (+5)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 25 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Stonepine Capital Management, LLCadded · filed 14 Aug 2026 | 4,990,238$9.6M | +4,197,949+529.9% |
| Nantahala Capital Management, LLCunchanged · filed 14 Aug 2026 | 1,086,812$2.3M | 00.0% |
| AWM Investment Company, Inc.unchanged · filed 14 Aug 2026 | 619,574$1.3M | 00.0% |
| VANGUARD CAPITAL MANAGEMENT LLCunchanged · filed 13 Aug 2026 | 261,146$561K | 00.0% |
| DIADEMA PARTNERS LPreduced · filed 14 Aug 2026 | 148,546$319K | -204,531−57.9% |
| TWO SIGMA INVESTMENTS, LPreduced · filed 14 Aug 2026 | 105,326$226K | -16,647−13.6% |
| RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026 | 104,823$225K | +11,100+11.8% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 93,647$201K | +1,011+1.1% |
| CITADEL ADVISORS LLCadded · filed 14 Aug 2026 | 49,414$106K | +12,573+34.1% |
| VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 2026 | 47,048$101K | 00.0% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.